Skip to main content
Premium Trial:

Request an Annual Quote

DeCode Genetics Slashes Q3 Net Loss, Increases Revenues

NEW YORK, Oct. 29 (GenomeWeb News) - DeCode Genetics drastically slashed its net loss for the third quarter and reported revenue growth today.

The company had $12.8 million in revenue million for the quarter, ending Sept. 30, compared to $9.0 million for the year-ago quarter. Net loss was $1.3 million, compared to $85.4 million for the same period in 2002.

 

The firm cut its research and development expenditures to $11.1 million for the quarter, compared to $23.9 million for the third quarter of 2002.

 

The Reykjavik, Icelandpopulation genomics company said it has million in cash and cash equivalents at the close of the quarter on Sept. 30.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.